Company intelligence / Profile preview

CorVent Medical

Fargo, North Dakota, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

The RESPOND ventilator provides ICU-quality respiratory support, including lifesaving, life-sustaining, and weaning modes, and is FDA 510(k) cleared. It is designed for reliable, affordable deployment with minimal maintenance requirements, targeting expansion of ventilation capacity in critical care settings.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Premier Inc. (hospital network group purchasing agreement)North Dakota State University (NDSU) (academic collaboration)North Dakota Department of Commerce/NDDF (financial partnership/investment)

Beyond the preview

Go deeper on CorVent Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CorVent Medical.

Explore the full profile